Financials

News Discussions Technicals Seasonals

BFK fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PHARMESIS INTL operating, investing, and financing activities

BFK free cash flow for H1 24 is -1.58 M SGD. For 2023, BFK free cash flow was -2.32 M SGD and operating cash flow was -2.2 M SGD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: SGD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—